PF-Atlas › Clinical Trials › NCT00255242
Effect of Simvastatin on CF Airway Inflammation
Simvastatin treatment for 28 days · Phase 1
Registry ID
NCT00255242
Phase
Phase 1
Status
Completed
Drug / intervention
Simvastatin treatment for 28 days
Sponsor
Akron Children's Hospital
Start
2004-07
About this trial
Simvastatin treatment for 28 days is evaluated in NCT00255242, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Akron Children's Hospital. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00255242 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.